Similar articles

• Influence of dopamine and thyrotropin releasing hormone on the volume of nuclei of prolactin cells in rat adenohypophysis in vitro.

  Lewiński A. Lewiński A. Endokrinologie. 1977 Jul;69(2):217-21. Endokrinologie. 1977. PMID: 410638
• Pituitary cyclic nucleotides and thyrotropin-releasing hormone action: the relationship of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate to the release of thyrotropin and prolactin.

  Naor Z, Snyder G, Fawcett CP, McCann SM. Naor Z, et al. Endocrinology. 1980 Apr;106(4):1304-10. Endocrinology. 1980. PMID: 6244151 No abstract available.
• Fate of thyrotropin releasing hormone after binding and stimulation of prolactin release by GH3 cells. Evidence for release of unmodified (3H)-TRH.

  Gourdji D, Tixier-Vidal A, Levine-Pinto H, Pradelles P, Morgat JL, Fromageot P. Gourdji D, et al. Neuroendocrinology. 1976;20(3):201-11. doi: 10.1159/000122484. Neuroendocrinology. 1976. PMID: 822368
• Pyroglutamyl-histidyl-prolineamide (TRH). A neurohormone which affects the release and synthesis of prolactin and thyrotropin.

  Dannies PS, Tashjian AH Jr. Dannies PS, et al. Isr J Med Sci. 1974 Oct;10(10):1294-304. Isr J Med Sci. 1974. PMID: 4215776 Review. No abstract available.
• Pituitary TRH receptors.

  Hinkle PM. Hinkle PM. Ann N Y Acad Sci. 1989;553:176-87. doi: 10.1111/j.1749-6632.1989.tb46639.x. Ann N Y Acad Sci. 1989. PMID: 2541649 Review. No abstract available.